With sickle cell disease study in sight, Graphite Bio draws up a $238M IPO
https://medcitynews.com/2021/06/with-sickle-cell-disease-study-in-sight-graphite-bio-draws-up-a-238m-ipo/
3D printers: Why you need to seriously start thinking about this technology
https://medcitynews.com/2021/06/3d-printers-why-you-need-to-seriously-start-thinking-about-this-technology/
Stopping the bleed of nursing turnover in the U.S.
https://medcitynews.com/2021/06/stopping-the-bleed-of-nursing-turnover-in-the-u-s/
StartUPDATES: New developments from healthcare startups
https://medcitynews.com/2021/06/startupdates-new-developments-from-healthcare-startups-33/
At a crossroads: Hospital execs staring down some of their toughest decisions yet
https://medcitynews.com/2021/06/at-a-crossroads-hospital-execs-staring-down-some-of-their-toughest-decisions-yet/
Doximity’s stock doubles after IPO. Here’s how it plans to keep the momentum going.
https://medcitynews.com/2021/06/doximitys-stock-doubles-after-ipo-heres-how-it-plans-to-keep-the-momentum-going/
Prisma Health, Siemens strike 10-year partnership
https://medcitynews.com/2021/06/prisma-health-siemens-strike-10-year-partnership/
AbbVie acquires TeneoOne to keep pace in chase for new multiple myeloma drugs
https://medcitynews.com/2021/06/abbvie-acquires-teneoone-to-keep-pace-in-chase-for-new-multiple-myeloma-drugs/
Hims & Hers buys dermatology business
https://medcitynews.com/2021/06/hims-hers-buys-dermatology-business/
Report: Quarterly health services deal volume hits record-high
https://medcitynews.com/2021/06/report-quarterly-health-services-deal-volume-hits-record-high/
